Excelestar Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Sealonixsealonix.comMay 2023
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures.
BiotechMedical DevicesNew MaterialsBedford, US
Amarpreet Sawhney(Executive Officer, Director)Amar Sawhney(Founder)
Co-investorsJ2 Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.